Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines-Reference-Cited by-同舟云学术

Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines

Published:2024-08-05 Issue:8 Volume:7 Page:5359-5368
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Bashiru Mujeebat¹^ORCID,Rayaan Muhammad¹,Ali Nawab²,Jenkins Samir V.³^ORCID,Oyebade Adeniyi¹,Rahman Md Shahedur¹,Griffin Robert J.³,Oyelere Adegboyega K.⁴,Siraj Noureen¹^ORCID

Affiliation:

1. Department of Chemistry, University of Arkansas at Little Rock, Little Rock, Arkansas 72204, United States

2. Department of Biology, University of Arkansas at Little Rock, Little Rock, Arkansas 72204, United States

3. Department of Radiation Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, Arkansas 72205, United States

4. School of Chemistry and Biochemistry, Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

Funder

National Institute of General Medical Sciences

National Science Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.4c00552

Reference41 articles.

1. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics

2. Endocytosis of nanomedicines

3. Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer

4. Enhanced photothermal heating and combination therapy of NIR dye via conversion to self-assembled ionic nanomaterials

5. Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer